View item

US Department of Defense – Orthotics and Prosthetics Outcomes Research Program (OPORP) – Clinical Trial Award (CTA)
Sponsor: US Department of Defense 		Closing Date: 06-Aug-2018
The OPORP Clinical Trial Award mechanism is being offered for the first time in FY18 and challenges the scientific community to address which orthotic and prosthetic devices, and which characteristics of those devices, generate the best patient outcomes. It is expected that research findings will have relevance to Service members and Veterans and also provide benefit to the general population.

This award mechanism is intended to support clinical trials that evaluate orthotic and/or prosthetic devices using patient-centric outcomes relevant to Service members and Veterans with limb loss and/or limb impairment.

Eligibility
• Independent investigators at all academic levels (or equivalent) are eligible to apply.

Key Mechanism Elements
• Supports rapid implementation of clinical trials with the potential to make significant impacts on improving health and well-being of Service members and Veterans with limb loss and/or limb deficit.
• Supports research that evaluates the comparative effectiveness of orthotic and/or prosthetic clinical interventions using patient-centric outcomes.
• Proposed projects should be designed to provide outcomes data regarding orthotic and/or prosthetic devices and must include the anticipated effect on patient care metrics.
• Collaboration among academia, industry, the DoD, and the VA is highly encouraged, including longitudinal outcome studies.
• Applications submitted to the FY18 OPORPCTA must address one or more of the FY18OPORP Focus Areas.
• Preclinical research is not allowed.
• Preproposal submission is required; application submission is by invitation only.

Funding
Funding Level 1:
• Maximum funding of USD $350,000 for total costs (direct costs plus indirect costs).
• Maximum period of performance is 2 years.

Funding Level 2:
• Maximum funding of USD $2,500,000 for total costs (direct costs plus indirect costs).
• Maximum period of performance is 4 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/oporp and http://cdmrp.army.mil/oporp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Pre-applications due to UQR&I: 23 July 2018
Pre-applications (mandatory) close with US Department of Defense: 6 August 2018
Invitation from U.S. Department of Defense to submit a full application: 5 September 2018
Invited full applications close with US Department of Defense: 25 October 2018

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/oporp

Return